Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Joy Benadiba, Celia Rosilio, Marielle Nebout, Vera Heimeroth, Zouhour Neffati, Alexandra Popa, Didier Mary, Emmanuel Griessinger, Véronique Imbert, Nicolas Sirvent & Jean-François Peyron. (2017) Iron chelation: an adjuvant therapy to target metabolism, growth and survival of murine PTEN-deficient T lymphoma and human T lymphoblastic leukemia/lymphoma. Leukemia & Lymphoma 58:6, pages 1433-1445.
Read now
Read now
Kathryn A. O'Donnell, Duonan Yu, Karen I. Zeller, Jung-whan Kim, Frederick Racke, Andrei Thomas-Tikhonenko & Chi V. Dang. (2006) Activation of Transferrin Receptor 1 by c-Myc Enhances Cellular Proliferation and Tumorigenesis. Molecular and Cellular Biology 26:6, pages 2373-2386.
Read now
Read now
Jane B. Trepel, Oscar R. Colamonici, Kathleen Kelly, Gisela Schwab, Rosemary A. Watt, Edward A. Sausville, Elaine S. Jaffe & Leonard M. Neckers. (1987) Transcriptional Inactivation of c-myc and the Transferrin Receptor in Dibutyryl Cyclic AMP-Treated HL-60 Cells. Molecular and Cellular Biology 7:7, pages 2644-2648.
Read now
Read now
Articles from other publishers (45)
Wei Huang, Gang Huang, Shuxian An & Jianjun Liu. (2023) Molecular imaging of pancreatic ductal adenocarcinoma. VIEW 4:5.
Crossref
Crossref
Caroline Plett, Lara Kristina Klauer, Daniel Christoph Amberger, Selda Ugur, Alexander Rabe, Zuzana Fischer, Diana Deen, Annika Hirn-Lopez, Carina Gunsilius, Jan-Ole Werner, Jörg Schmohl, Doris Krämer, Andreas Rank, Christoph Schmid & Helga Maria Schmetzer. (2022) Immunomodulatory kits generating leukaemia derived dendritic cells do not induce blast proliferation ex vivo: IPO-38 as a novel marker to quantify proliferating blasts in acute myeloid leukaemia. Clinical Immunology 242, pages 109083.
Crossref
Crossref
Takuya Shirakihara, Hideki Yamaguchi, Tadashi Kondo, Masakazu Yashiro & Ryuichi Sakai. (2022) Transferrin receptor 1 promotes the fibroblast growth factor receptor-mediated oncogenic potential of diffused-type gastric cancer. Oncogene 41:18, pages 2587-2596.
Crossref
Crossref
Isha Gaurav, Xuehan Wang, Abhimanyu Thakur, Ashok Iyaswamy, Sudha Thakur, Xiaoyu Chen, Gaurav Kumar, Min Li & Zhijun Yang. (2021) Peptide-Conjugated Nano Delivery Systems for Therapy and Diagnosis of Cancer. Pharmaceutics 13:9, pages 1433.
Crossref
Crossref
K Kobayashi, M Suzukawa, K Watanabe, S Arakawa, S Igarashi, I Asari, A Hebisawa, H Matsui, H Nagai, T Nagase & K Ohta. (2020) Secretory IgA accumulated in the airspaces of idiopathic pulmonary fibrosis and promoted VEGF, TGF-β and IL-8 production by A549 cells. Clinical and Experimental Immunology 199:3, pages 326-336.
Crossref
Crossref
Songtao Li, Hongling Zhao, Yanfang Fan, Guiqin Zhao, Ruxing Wang, Fuyu Wen, Jianping Wang, Xiaohui Wang, Yu Wang & Yang Gao. (2019) Design, synthesis, and in vitro antitumor activity of a transferrin receptor‐targeted peptide–doxorubicin conjugate. Chemical Biology & Drug Design 95:1, pages 58-65.
Crossref
Crossref
Songtao Li, Hongling Zhao, Xiaoxia Mao, Yanfang Fan, Xiujun Liang, Ruxing Wang, Lijun Xiao, Jianping Wang, Qi Liu & Guiqin Zhao. (2019) Transferrin Receptor Targeted Cellular Delivery of Doxorubicin Via a Reduction-Responsive Peptide-Drug Conjugate. Pharmaceutical Research 36:12.
Crossref
Crossref
Jiuyang He, Kelong Fan & Xiyun Yan. (2019) Ferritin drug carrier (FDC) for tumor targeting therapy. Journal of Controlled Release 311-312, pages 288-300.
Crossref
Crossref
Kelong Fan & Xiyun Yan. 2018. Handbook of Nanomaterials for Cancer Theranostics. Handbook of Nanomaterials for Cancer Theranostics
143
175
.
Aya Sugyo, Atsushi B. Tsuji, Hitomi Sudo, Fumiko Nomura, Hirokazu Satoh, Mitsuru Koizumi, Gene Kurosawa, Yoshikazu Kurosawa & Tsuneo Saga. (2017) Uptake of 111In-labeled fully human monoclonal antibody TSP-A18 reflects transferrin receptor expression in normal organs and tissues of mice. Oncology Reports 37:3, pages 1529-1536.
Crossref
Crossref
Masayori Hagimori, Yuki Fuchigami & Shigeru Kawakami. (2017) Peptide-Based Cancer-Targeted DDS and Molecular Imaging. CHEMICAL & PHARMACEUTICAL BULLETIN Chemical and Pharmaceutical Bulletin 65:7, pages 618-624.
Crossref
Crossref
Elham Sadat Mirfazeli, Sayed-Amir Marashi & Shiva Kalantari. (2016) In silico prediction of specific pathways that regulate mesangial cell proliferation in IgA nephropathy. Medical Hypotheses 97, pages 38-45.
Crossref
Crossref
Victor G. Mihucz, Florian Meirer, Zs?fia Polg?ri, Andrea R?ti, Giancarlo Pepponi, Dieter Ingerle, Norbert Szoboszlai & Christina Streli. (2016) Iron overload of human colon adenocarcinoma cells studied by synchrotron-based X-ray techniques. JBIC Journal of Biological Inorganic Chemistry 21:2, pages 241-249.
Crossref
Crossref
Aya Sugyo, Atsushi B. Tsuji, Hitomi Sudo, Maki Okada, Mitsuru Koizumi, Hirokazu Satoh, Gene Kurosawa, Yoshikazu Kurosawa & Tsuneo Saga. (2015) Evaluation of Efficacy of Radioimmunotherapy with 90Y-Labeled Fully Human Anti-Transferrin Receptor Monoclonal Antibody in Pancreatic Cancer Mouse Models. PLOS ONE 10:4, pages e0123761.
Crossref
Crossref
Aya Sugyo, Atsushi B. Tsuji, Hitomi Sudo, Kotaro Nagatsu, Mitsuru Koizumi, Yoshinori Ukai, Gene Kurosawa, Ming-Rong Zhang, Yoshikazu Kurosawa & Tsuneo Saga. (2015) Preclinical evaluation of 89Zr-labeled human antitransferrin receptor monoclonal antibody as a PET probe using a pancreatic cancer mouse model. Nuclear Medicine Communications 36:3, pages 286-294.
Crossref
Crossref
MinJung Kim, Yee Sun Tan, Wen-Chih Cheng, Tami J. Kingsbury, Shelly Heimfeld & Curt I. Civin. (2015)
MIR144
and
MIR451
regulate human erythropoiesis via RAB14
. British Journal of Haematology 168:4, pages 583-597.
Crossref
Crossref
Jia-zeng Sun, Jigui Wang, Shuang Wang, Daoli Yuan, Zhili Li, Bao Yi, Qiang Hou, Yaping Mao & Weiquan Liu. (2014) MicroRNA miR-320a and miR-140 inhibit mink enteritis virus infection by repression of its receptor, feline transferrin receptor. Virology Journal 11:1.
Crossref
Crossref
Stephanie Tortorella & Tom C. Karagiannis. (2014) Transferrin Receptor-Mediated Endocytosis: A Useful Target for Cancer Therapy. The Journal of Membrane Biology 247:4, pages 291-307.
Crossref
Crossref
Kelong Fan, Lizeng Gao & Xiyun Yan. (2013) Human ferritin for tumor detection and therapy. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 5:4, pages 287-298.
Crossref
Crossref
Christine DufèsMajed Al Robaian & Sukrut Somani. (2013) Transferrin and the transferrin receptor for the targeted delivery of therapeutic agents to the brain and cancer cells. Therapeutic Delivery 4:5, pages 629-640.
Crossref
Crossref
Willem van de Veen, Barbara Stanic, Görkem Yaman, Marcin Wawrzyniak, Stefan Söllner, Deniz G. Akdis, Beate Rückert, Cezmi A. Akdis & Mübeccel Akdis. (2013) IgG4 production is confined to human IL-10–producing regulatory B cells that suppress antigen-specific immune responses. Journal of Allergy and Clinical Immunology 131:4, pages 1204-1212.
Crossref
Crossref
Megumi Kawamoto, Masayuki Kohno, Tomohisa Horibe & Koji Kawakami. (2013) Immunogenicity and toxicity of transferrin receptor-targeted hybrid peptide as a potent anticancer agent. Cancer Chemotherapy and Pharmacology 71:3, pages 799-807.
Crossref
Crossref
Yusuke Yoshioka, Nobuyoshi Kosaka, Takahiro Ochiya & Takashi Kato. (2012) Micromanaging Iron Homeostasis. Journal of Biological Chemistry 287:41, pages 34110-34119.
Crossref
Crossref
Jason P Holland, Michael J Evans, Samuel L Rice, John Wongvipat, Charles L Sawyers & Jason S Lewis. (2012) Annotating MYC status with 89Zr-transferrin imaging. Nature Medicine 18:10, pages 1586-1591.
Crossref
Crossref
Zeng Wang, Wei Hu, Jia-Li Zhang, Xiu-Hua Wu & Hui-Jun Zhou. (2012) Dihydroartemisinin induces autophagy and inhibits the growth of iron-loaded human myeloid leukemia K562 cells via ROS toxicity. FEBS Open Bio 2:1, pages 103-112.
Crossref
Crossref
Megumi Kawamoto, Tomohisa Horibe, Masayuki Kohno & Koji Kawakami. (2011) A novel transferrin receptor-targeted hybrid peptide disintegrates cancer cell membrane to induce rapid killing of cancer cells. BMC Cancer 11:1.
Crossref
Crossref
Jinlong Jian, Qing Yang & Xi Huang. (2011) Src Regulates Tyr20 Phosphorylation of Transferrin Receptor-1 and Potentiates Breast Cancer Cell Survival. Journal of Biological Chemistry 286:41, pages 35708-35715.
Crossref
Crossref
Gaetano MagroIvana CataldoPaolo AmicoAntonietta TorrisiGiada Maria VecchioRosalba ParentiSofia AsioliDaniele RecuperoVelia D'AgataMaria Teresa MucignatRoberto Perris. (2011) Aberrant Expression of TfR1/CD71 in Thyroid Carcinomas Identifies a Novel Potential Diagnostic Marker and Therapeutic Target. Thyroid 21:3, pages 267-277.
Crossref
Crossref
X. Shen, G.-b. Hu, S.-j. Jiang, F.-r. He, W. Xing, L. Li, J. Yang, H.-f. Zhu, P. Lei & G.-x. Shen. (2009) Engineering and characterization of a baculovirus-expressed mouse/human chimeric antibody against transferrin receptor. Protein Engineering Design and Selection 22:12, pages 723-731.
Crossref
Crossref
Dale G. Schaar, Daniel J. Medina, Dirk F. Moore, Roger K. Strair & Yi Ting. (2009) miR-320 targets transferrin receptor 1 (CD71) and inhibits cell proliferation. Experimental Hematology 37:2, pages 245-255.
Crossref
Crossref
C Callens, I C Moura, Y Lepelletier, S Coulon, A Renand, M Dussiot, D Ghez, M Benhamou, R C Monteiro, A Bazarbachi & O Hermine. (2007) Recent advances in adult T-cell leukemia therapy: focus on a new anti-transferrin receptor monoclonal antibody. Leukemia 22:1, pages 42-48.
Crossref
Crossref
Andrea Cicconetti, Benedetto Sacchetti, Adriano Bartoli, Stefano Michienzi, Alessandro Corsi, Alessia Funari, Pamela Gehron Robey, Paolo Bianco & Mara Riminucci. (2007) Human maxillary tuberosity and jaw periosteum as sources of osteoprogenitor cells for tissue engineering. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 104:5, pages 618.e1-618.e12.
Crossref
Crossref
Tracy R. Daniels, Tracie Delgado, Jose A. Rodriguez, Gustavo Helguera & Manuel L. Penichet. (2006) The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer. Clinical Immunology 121:2, pages 144-158.
Crossref
Crossref
Philip G. Cavanaugh & Garth L. Nicolson. (1998) Selection of highly metastatic rat MTLn2 mammary adenocarcinoma cell variants using in vitro growth response to transferrin. Journal of Cellular Physiology 174:1, pages 48-57.
Crossref
Crossref
Philip S. Rudland, Roger Barraclough, David G. Fernig & John A. Smith. 1997. Stem Cells. Stem Cells
147
232
.
NELLY NORAZ, BERNARD VERRIER, CHRISTOPHE FRAISIER & CLAUDE DESGRANGES. (1995) Cell Surface Phenotypic Changes Induced in H9 T Cells Chronically Infected with HTLV Type I or HIV Type 1 or Coinfected with the Two Viruses. AIDS Research and Human Retroviruses 11:1, pages 145-154.
Crossref
Crossref
Alan Winkelstein, Richard A. Hess, Kimberly D. Leichtling, Melany O. Jackson, R.Michael Blaese & Leslie D. Weaver. (1992) Inhibition of human lymphoproliferative responses and altered lymphocyte membrane phenotype by succinylacetone. Immunopharmacology 24:3, pages 161-170.
Crossref
Crossref
Philip G. Cavanaugh & Garth L. Nicolson. (2004) Lung‐derived growth factor that stimulates the growth of lung‐metastasizing tumor cells: Identification as transferrin. Journal of Cellular Biochemistry 47:3, pages 261-271.
Crossref
Crossref
S. Denstman, R. Hromchak, X.P. Guan & A. Bloch. (1991) Identification of transferrin as a progression factor for ML-1 human myeloblastic leukemia cell differentiation. Journal of Biological Chemistry 266:23, pages 14873-14876.
Crossref
Crossref
I. BAşAR, A. AYHAN, K. BiRCAN, A. ERGEN & ¸. TAşAR. (1991) Transferrin Receptor Activity as a Marker in Transitional Cell Carcinoma of the Bladder. British Journal of Urology 67:2, pages 165-168.
Crossref
Crossref
Harold N. Keer, James M. Kozlowski, Yvonne C. Tsai, Chung Lee, Robert N. McEwan & John T. Grayhack. (1990) Elevated Transferrin Receptor Content in Human Prostate Cancer Cell Lines Assessed in Vitro and in Vivo. The Journal of Urology 143:2, pages 381-385.
Crossref
Crossref
G. J. Anderson, W. Page Faulk, P. Arosio, D. Moss, L. W. Powell & J. W. Halliday. (2008) Identification of H‐ and L‐ferritin subunit binding sites on human T and B lymphoid cells. British Journal of Haematology 73:2, pages 260-264.
Crossref
Crossref
Kimberly Kline, Laurie A. Plante, Thomas J. MorganJr.Jr. & Bob G. Sanders. (1989) Chicken transferrin receptor expression during erythroid differentiation and by retrovirus transformed cells. Developmental & Comparative Immunology 13:3, pages 231-252.
Crossref
Crossref
David N. Ernst, Donald N. McQuitty, William O. Weigle & Monte V. Hobbs. (1988) Expression of membrane activation antigens on murine B lymphocytes stimulated with lipopolysaccharide. Cellular Immunology 114:1, pages 161-173.
Crossref
Crossref
L. M. Neckers & R. P. Nordan. (1988) Regulation of murine plasmacytoma transferrin receptor expression and G1 traversal by plasmacytoma cell growthfactor. Journal of Cellular Physiology 135:3, pages 495-501.
Crossref
Crossref